Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform

Wednesday, September 20, 2023 1 min read

Key Takeaway: Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform

Full Press Release Details

Kyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platform.